Results 121 to 130 of about 4,399 (136)

Polydatin attenuates orbital oxidative stress in Graves’ orbitopathy through the NRF2 pathway

Chemico-Biological Interactions, 2020
Hong Li, Jie Min
exaly  

Adipocytokines in Graves’ orbitopathy and the effect of high-dose corticosteroids

Adipocyte, 2021
Jan Schovanek, Michal Krupka, Ľubica Cibičková   +2 more
exaly  

Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study

Lancet, The, 2000
Maarten P Mourits, Caroline B Terwee, Maarten Ph Mourits   +2 more
exaly  

Natural history of graves’ orbitopathy after treatment

Endocrine, 2016
Marenza Leo, Elena Sabini, Marco Nardi   +2 more
exaly  

Evaluating Graves’ Orbitopathy

Best Practice and Research in Clinical Endocrinology and Metabolism, 2012
Peter J Dolman
exaly  

Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application

Therapeutic Advances in Endocrinology and Metabolism, 2020
George J Kahaly
exaly  

Outcome of Deep Lateral Wall Rim-Sparing Orbital Decompression in Thyroid-associated Orbitopathy: A New Technique and Results of a Case Series

Orbit, 2011
Purnima Mehta
exaly  

Color Doppler imaging of the superior ophthalmic vein in different clinical forms of Graves’ orbitopathy

Japanese Journal of Ophthalmology, 2008
Mario L R Monteiro, Monteiro Mario L R
exaly  

Place of radiotherapy in the treatment of Graves’ orbitopathy

International Journal of Radiation Oncology Biology Physics, 1999
V Beckendorf, T Maalouf, P Bey
exaly  

Lower Eyelid Contour in Graves Orbitopathy

Current Eye Research, 2019
Denny Marcos Garcia
exaly